MARC E LIPPMAN Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARC E LIPPMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARC E LIPPMAN. MARC E LIPPMAN is Director in SEATTLE GENETICS INC /WA ($SGEN).
MARC E LIPPMAN in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MARC E LIPPMAN: Director
Holdings: 140,908 shares
Current Value: $8,565,797
Latest Transaction: Nov 05 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARC E LIPPMAN in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 56.77 | 9,260 | 525,690 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 39.94 | 9,260 | 369,844 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 38.82 | 9,260 | 359,473 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 36.70 | 8,750 | 321,125 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 34.25 | 8,750 | 299,688 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 20.06 | 12,784 | 256,447 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 20.06 | 4,716 | 94,603 | 12,784 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 169.80 | 14,064 | 2,388,067 | 52,338 | 66.4 K to 52.3 K (-21.18 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.89 | 65,246 | 11,019,397 | 66,402 | 131.6 K to 66.4 K (-49.56 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 167.10 | 12,784 | 2,136,206 | 131,648 | 144.4 K to 131.6 K (-8.85 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 20.06 | 12,784 | 256,447 | 144,432 | 131.6 K to 144.4 K (+9.71 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 167.97 | 4,716 | 792,147 | 131,648 | 136.4 K to 131.6 K (-3.46 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 20.06 | 4,716 | 94,603 | 136,364 | 131.6 K to 136.4 K (+3.58 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.11 | 8,750 | 1,470,963 | 131,648 | 140.4 K to 131.6 K (-6.23 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 36.70 | 8,750 | 321,125 | 140,398 | 131.6 K to 140.4 K (+6.65 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.32 | 8,750 | 1,472,800 | 131,648 | 140.4 K to 131.6 K (-6.23 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 34.25 | 8,750 | 299,688 | 140,398 | 131.6 K to 140.4 K (+6.65 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.39 | 9,260 | 1,559,291 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 39.94 | 9,260 | 369,844 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.42 | 9,260 | 1,559,569 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 38.82 | 9,260 | 359,473 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.45 | 9,260 | 1,559,847 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 56.77 | 9,260 | 525,690 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 56.77 | 9,260 | 525,690 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 39.94 | 9,260 | 369,844 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 38.82 | 9,260 | 359,473 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 36.70 | 8,750 | 321,125 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 34.25 | 8,750 | 299,688 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 20.06 | 12,784 | 256,447 | 0 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Option Exercise | M | 20.06 | 4,716 | 94,603 | 12,784 | |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 169.80 | 14,064 | 2,388,067 | 52,338 | 66.4 K to 52.3 K (-21.18 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.89 | 65,246 | 11,019,397 | 66,402 | 131.6 K to 66.4 K (-49.56 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 167.10 | 12,784 | 2,136,206 | 131,648 | 144.4 K to 131.6 K (-8.85 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 20.06 | 12,784 | 256,447 | 144,432 | 131.6 K to 144.4 K (+9.71 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 167.97 | 4,716 | 792,147 | 131,648 | 136.4 K to 131.6 K (-3.46 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 20.06 | 4,716 | 94,603 | 136,364 | 131.6 K to 136.4 K (+3.58 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.11 | 8,750 | 1,470,963 | 131,648 | 140.4 K to 131.6 K (-6.23 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 36.70 | 8,750 | 321,125 | 140,398 | 131.6 K to 140.4 K (+6.65 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.32 | 8,750 | 1,472,800 | 131,648 | 140.4 K to 131.6 K (-6.23 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 34.25 | 8,750 | 299,688 | 140,398 | 131.6 K to 140.4 K (+6.65 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.39 | 9,260 | 1,559,291 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 39.94 | 9,260 | 369,844 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.42 | 9,260 | 1,559,569 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 38.82 | 9,260 | 359,473 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Sell | S | 168.45 | 9,260 | 1,559,847 | 131,648 | 140.9 K to 131.6 K (-6.57 %) |
| Nov 05 2020 | SGEN | Seagen Inc. | LIPPMAN MARC E | Director | Buy | M | 56.77 | 9,260 | 525,690 | 140,908 | 131.6 K to 140.9 K (+7.03 %) |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 160.33 | 3,171 | 508,406 | 3,171 | |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 1,335 | 0 | 131,648 | 130.3 K to 131.6 K (+1.02 %) |
| May 06 2020 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Sell | S | 152.03 | 1,000 | 152,030 | 130,313 | 131.3 K to 130.3 K (-0.76 %) |
| Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | M | 19.02 | 17,500 | 332,850 | 0 | |
| Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | M | 12.76 | 17,500 | 223,300 | 0 | |
| Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Sell | S | 115.43 | 17,500 | 2,020,025 | 131,313 | 148.8 K to 131.3 K (-11.76 %) |
| Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Buy | M | 12.76 | 17,500 | 223,300 | 148,813 | 131.3 K to 148.8 K (+13.33 %) |
| Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Sell | S | 116.17 | 17,500 | 2,032,975 | 131,313 | 148.8 K to 131.3 K (-11.76 %) |
| Nov 20 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Buy | M | 19.02 | 17,500 | 332,850 | 148,813 | 131.3 K to 148.8 K (+13.33 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 2,963 | 0 | 131,313 | 128.4 K to 131.3 K (+2.31 %) |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
| May 22 2019 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 2,963 | 0 | 131,313 | 128.4 K to 131.3 K (+2.31 %) |
| Aug 02 2018 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Sell | S | 69.25 | 7,400 | 512,450 | 128,350 | 135.8 K to 128.4 K (-5.45 %) |
| May 22 2018 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
| May 22 2018 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 3,700 | 0 | 135,750 | 132.1 K to 135.8 K (+2.80 %) |
| Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Sell | S | 58.07 | 3,000 | 174,224 | 132,050 | 135.1 K to 132.1 K (-2.22 %) |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 3,700 | 0 | 135,050 | 131.4 K to 135.1 K (+2.82 %) |
| Nov 09 2016 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Sell | S | 57.75 | 1,000 | 57,749 | 131,350 | 132.4 K to 131.4 K (-0.76 %) |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 38.82 | 9,260 | 359,473 | 9,260 | |
| May 24 2016 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 3,700 | 0 | 132,350 | 128.7 K to 132.4 K (+2.88 %) |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 39.94 | 9,260 | 369,844 | 9,260 | |
| May 19 2015 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 3,700 | 0 | 128,650 | 125 K to 128.7 K (+2.96 %) |
Page: 1